Coagulation Analyzer Market to Grow at a CAGR of 9.8% During the Forecast Period 2020-2025

Coagulation/Hemostasis Analyzer Market size in 2019 is estimated to be $3.3 billion, growing at a CAGR of 9.8% during the forecast period 2020-2025. Coagulation/Hemostasis Analyzer provide measurement of Blood platelet levels in a quick and simple process. It is a device that measure speed of coagulation pathway and thrombolin and thromboplastin levels in less time. It helps to provide diagnostic prevention from heart attack including blood clot also it is used to detect clotting deficiencies related diseases such as hemophilia von Willebrand disease and other conditions. Increasing prevalence of Cardiovascular diseases and blood disorders coupled with rising geriatric population are the major factors driving the growth of the market. Moreover, growing laboratory automation further enhance the overall market demand for Coagulation/Hemostasis Analyzer during the forecast period 2020-2025.

Coagulation/Hemostasis Analyzer Market Segment Analysis – By Product Type

Based on the Product Type, Coagulation/Hemostasis Analyzer Market is segmented into Clinical Laboratory Analyzers, Point-Of-Care Testing Analyzers, Consumables, Automated Analyzers. The Clinical Laboratory Analyzers segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 7.6% during the forecast period 2020-2025. This is mainly owing to it mostly being used in hospitals for hematological analysis of patients. Moreover, it is fast and quick for testing, contributing to the growth of this segment.

Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=16786

Report Price: $ 4500 (Single User License)

Coagulation/Hemostasis Analyzer Market Segment Analysis – By Test

Based on the Test, Coagulation/Hemostasis Analyzer Market is segmented into APTT Tests, D dimer Tests, Fibrinogen Tests, Prothrombin Time Tests. In 2019, Prothrombin Time Tests held the largest share in the Coagulation/Hemostasis Analyzers market. This is mainly owing to high usage of Prothrombin Time Tests as it measures the time it takes for blood plasma to clot. Moreover, Prothrombin Time Tests helps to detect bleeding problems is also contributing to the growth of this segment.

Coagulation/Hemostasis Analyzer Market Segment Analysis – By End User

Based on the end user, Coagulation/Hemostasis Analyzer Market is segmented into Clinical Laboratories, Point-Of-Care Testing, Research and Development Organisations, Others. In 2019, Clinical Laboratories held the largest share in the Coagulation/Hemostasis Analyzers market. This is mainly owing to large volume of coagulation testing being performed at clinical laboratories. Moreover, government support towards setup and testing is also contributing to the growth of this segment.

Coagulation/Hemostasis Analyzer Market Segment Analysis – Geography

North America dominated the Coagulation/Hemostasis Analyzer market share accounting for 43% of the market in 2019. This is mainly owing to increasing prevalence blood disorders in this region. According to American Society of Hematology, Anemia is most common blood disorder in America and around 3 million Americans affects anemia. Lack of iron among these patients increase the risk of clots.

However, the Asia-Pacific region is projected to be the fastest-growing during the forecast period 2020-2025. This is owing to increasing awareness among people about blood disorder conditions coupled with rising geriatric population.

Coagulation/Hemostasis Analyzer Market Drivers

Increasing prevalence of Diseases

Increasing prevalence of blood disorder conditions, as well as various cardiovascular diseases among the population globally, are driving the growth of Coagulation/Hemostasis Analyzer market. According to, World Federation of Hemophilia, in 2018, 337,000 people living with bleeding disorders in the world. According to World Health Organization (WHO), cardiovascular diseases are the leading cause of death in globally, and cause around 17.9 million deaths annually in worldwide.

Growing Technology Advancement

Growing technological advancement such as laboratory automation are some factors driving the growth of the market. Moreover, development of high-sensitivity point of care (POC) coagulation testing further contributing to the growth of Coagulation/Hemostasis Analyzer Market.

Download Sample Report @ https://www.industryarc.com/pdfdownload.php?id=16786

Coagulation/Hemostasis Analyzer Market Challenges

High cost of fully automated coagulation analyzer coupled with slow acceptance of advance hemostasis instrument in emerging economies are challenging the growth of the market. Moreover, strict regulatory policies for medical equipment are further restraining its market growth in certain regions during the forecast period 2020-2025.

Coagulation/Hemostasis Analyzer Industry Outlook

Product launches, Merger & Acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Coagulation/Hemostasis Analyzer Market. Coagulation/Hemostasis Analyzer top 10 companies are Abbott Laboratories, Siemens Healthineers Group, Thermo Fisher Scientific, Biosystems S.A., Sysmex Corporation, A&T Corporation, Roche Diagnostics, International Technidyne Corporation (ITC), Nihon Kohden Corporation, Alere Inc.

Acquisitions/Product Launches:

In December 2018, Sysmex Corporation, a leading company in blood coagulation analyzers has launched Automated Blood Coagulation Analyzers CN-6000 and CN-3000.

In May 2018, Beckman Coulter has launched DxH 900 hematology analyzer and it is available in Europe, U.S., Australia and New Zealand.

Key Takeaways

In 2019, North America dominates the Coagulation/Hemostasis Analyzer Market owing to increasing prevalence of blood disorders conditions.

Increasing geriatric population coupled with rising prevalence of cardiovascular diseases are driving the market growth of Coagulation/Hemostasis Analyzer.

Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Coagulation/Hemostasis Analyzer Market report.

High cost of automated Coagulation analyzers and slow acceptance of advance hemostasis instrument in emerging economies are challenging the growth of the market.

Related Reports :

A. Blood Gas Analyzer Market

https://www.industryarc.com/Report/16806/blood-gas-analyzer-blood-gas-electrolyte-analyzer-market.html

B. Blood Collection Tubes Market

https://www.industryarc.com/Report/15705/blood-collection-tubes-market.html

For more Lifesciences and Healthcare Market reports, Please click here

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

Tags: , , , , , ,

See Campaign: https://www.industryarc.com/reports/request-quote?id=16786
Contact Information:
Venkat Reddy Sales Director Email: venkat@industryarc.com Website: https://www.industryarc.com Phone: (+1) 970-236-3677

Tags:
, Wire, Extended Distribution, iCN Internal Distribution, Research Newswire, English

image

Contact Information:

Venkat Reddy
Sales Director
Email: venkat@industryarc.com
Website: https://www.industryarc.com
Phone: (+1) 970-236-3677

The post Coagulation Analyzer Market to Grow at a CAGR of 9.8% During the Forecast Period 2020-2025 appeared first on Financial Market News.